Anbio Biotechnology reported asset growth of 59.83% for the quarter ended Dec 2025. These growth metrics cover 2 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2024 | Dec2025 |
|---|---|---|
| Growth Ratios | ||
| Assets Growth (1y) | 19.67% | 59.83% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 21.40% | -33.96% |